Analyst Upgrades: TransEnterix, Inc., Ollie's Bargain Outlet Holdings Inc, and Bed Bath & Beyond Inc.

Analysts upwardly revised their ratings and price targets on TransEnterix, Inc. (NYSEMKT:TRXC), Ollie's Bargain Outlet Holdings Inc (NASDAQ:OLLI), and Bed Bath & Beyond Inc. (NASDAQ:BBBY)

Apr 7, 2016 at 9:18 AM
facebook twitter linkedin

Analysts are weighing in on medical device stock TransEnterix, Inc. (NYSEMKT:TRXC), as well as retailers Ollie's Bargain Outlet Holdings Inc (NASDAQ:OLLI) and Bed Bath & Beyond Inc. (NASDAQ:BBBY). Here's a quick roundup of today's bullish brokerage notes on TRXC, OLLI, and BBBY.
  • TRXC is set to add another 3.4% this morning, as excitement builds ahead of a key Food and Drug Administration (FDA) decision. The stock has added over 30% this week, closing Wednesday at $5.69 after tapping an annual high of $6.10. With bulls rushing into TransEnterix, Inc.'s options pits, analysts are also getting in on the action. Lake Street this morning reiterated its "buy" opinion on the shares, along with a $7 price target. However, this is just more of the same from Wall Street, where every single brokerage tracking TRXC recommends buying it. 
  • OLLI is pointed almost 10% higher in electronic trading, thanks to better-than-expected fiscal fourth-quarter earnings. The stock has already outpaced the S&P 500 Index (SPX) by nearly 16 percentage points in the past three months to trade at $22.70, but analysts are still expecting more. Just this morning, Piper Jaffray upped its rating on Ollie's Bargain Outlet Holdings Inc to "overweight," with a price-target hike to $28. No fewer than three other analysts also raised their price targets, which may have short sellers scared. More than one-fourth of OLLI's float is sold short, accounting for 12 sessions' worth of trading, at the stock's typical daily volume.  
  • BBBY is eyeing a 2.6% pop when the market opens, after the company beat the Street's expectations in the earnings confessional and announced a new quarterly dividend. Goldman Sachs and Baird raised their respective price targets on Bed Bath & Beyond Inc. to $52 and $51, and there's a good chance the stock could receive more bullish attention in the near term. Specifically, just one of the 17 brokerages tracking BBBY recommends buying it. And at their Wednesday close of $48.81, the shares are up more than 18% since hitting a five-year low of $41.26 in early February. 
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 


300x250 - Banner 3 - v1